This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (30)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Carolyn J. Pearce, MD; F. M. Gonzalez, MD; J. David Wallin, MD

Arch Intern Med. 1993;153(8):1000-1002.

Abstract
Three patients who were treated with ketorolac tromethamine (Toradol), an injectable nonsteroidal anti-inflammatory drug for pain management, developed acute renal failure or hyperkalemia or both. These complications were reversible in two cases after discontinuing the drug. Clinical conditions preexisted in each patient that rendered them susceptible to the renal complications of nonsteroidal anti-inflammatory use. It is well known that caution should be observed while using nonsteroidal anti-inflammatory drugs in patients whose renal function may be preserved through prostaglandin-mediated vasodilatory effects. The same cautions apply to ketorolac. Since its major marketed use is as an analgesic and its potent effect on prostaglandin synthesis may not be well recognized, those cautions must be emphasized.

(Arch Intern Med. 1993;153:1000-1002)

Author Affiliations
From the Louisiana State University School of Medicine, New Orleans.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery{dagger}
Forrest et al.
Br J Anaesth 2002;88:227-233.
ABSTRACT | FULL TEXT  

Diclofenac Does Not Decrease Renal Blood Flow or Glomerular Filtration In Elderly Patients Undergoing Orthopedic Surgery
Fredman et al.
Anesth. Analg. 1999;88:149-154.
ABSTRACT | FULL TEXT